Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.

Journal of vascular surgery - 1 Mar 2017

Brewster Luke, Robinson Scott, Wang Ruoya, Griffiths Sarah, Li Haiyan, Peister Alexandra, Copland Ian, McDevitt Todd

Abstract excerpt

BACKGROUND: Critical limb ischemia (CLI) is a life- and limb-threatening condition affecting 1% to 10% of the population with peripheral arterial disease. Traditional revascularization options are not possible for up to 50% of CLI patients, in which case, the use of cellular therapies, such as bone marrow-derived mesenchymal stem cells (MSCs), hold great promise as an alternative revascularization therapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipogenesis
Share to Angiogenic Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Critical Illness

Share to Diabetic Angiopathies

Share to Ischemia

Share to Lower Extremity

Share to Neovascularization, Physiologic

Source

Open in PubMed Open full text

Identifiers

PMID: 26921003
DOI: 10.1016/j.jvs.2015.02.061
PMCID: PMC4996777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.PMID 26921003Read ↗

Angiogenic cell therapy for critical limb ischemia: an update on concepts and trials.Semantic proximity Read ↗

Fibroblast growth factor and vascular endothelial growth factor play a critical role in endotheliogenesis from human adipose-derived stem cells.Semantic proximity Read ↗

Novel culture media enhances mononuclear cells from patients with chronic limb-threatening ischemia to increase vasculogenesis and anti-inflammatory effectSemantic proximity Read ↗

Identification of CD141+vasculogenic precursor cells from human bone marrow and their endothelial engagement in the arteriogenesis by co-transplantation with mesenchymal stem cellsSemantic proximity Read ↗

Human Bone Marrow-Derived, Pooled, Allogeneic Mesenchymal Stromal Cells Manufactured From Multiple Donors at Different Times Show Comparable Biological Functions in Vitro, and in Vivo to Repair Limb IschemiaSemantic proximity Read ↗

An Assessment of the Functional State of Endothelial Colony Forming Cells from Patients with Diabetes Mellitus and Chronic Limb Threatening IschemiaSemantic proximity Read ↗

Single cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemiaSemantic proximity Read ↗

Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.Semantic proximity Read ↗

Preclinical Evaluation of Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb IschemiaSemantic proximity Read ↗

Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity.Semantic proximity Read ↗

PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients.Semantic proximity Read ↗

Purification and Long-Term Expansion of Multipotent Endothelial-Like Cells with Potential Cardiovascular RegenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.